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Has the time arrived for clinical epidemiologists to routinely
use ‘routinely collected data’?The comparative effectiveness movement has rightly
concluded that experimental designs can only address
one segment of the most important questions and that
we just have to find robust ways to use routinely collected
data. In this issue, Benchimol et al. outline in a commen-
tary the importance of developing guidelines for the Re-
porting of studies Conducted using Routinely collected
Data (RECORD) statement. This includes guidelines for
use of health administrative data, data warehouses of elec-
tronic medical records, primary care medical record data,
and disease registries. The RECORD guidelines will be
developed in close conjunction with members of the
STROBE group to ensure consistent methods and to make
this a useful addition to the original STROBE statement.
This process will involve general consultation with stake-
holders, a formal Delphi process, and the eventual produc-
tion of useful and widely accepted reporting guidelines.
Details for joining the process are included in the article
should JCE readers be interested in joining the process
as a stakeholder.
In 1997 Bain et al. published an article entitled ‘‘Routinely
collected data in national and regional databases-an under-
used resource’’ [1]. They argued that routinely collected data
may be used in a number of different ways beyond their tra-
ditional uses for population health assessments and health
service planning; the strengths of the best routinely collected
databases are their population coverage, large number of
subjects, long duration, and their low cost. They have been
used by a minority of clinical epidemiologists because of
concerns about quality and the absence of clinical data on as-
pects such a clinical severity. Impressive advances on both
these fronts have been made. The time has come for this to
be reassessed, and indeed now there are ongoing constructive
discussions between clinical epidemiologists, pharmaco-
epidemiologists, health services, public health, and health
systems researchers within the Cochrane Collaboration.
Fortunately, there have been major advances in establishing
high-quality representative administrative databases that
can be linked with clinical registries and other databases to
evaluate the impact of important aspects of clinical care, pub-
lic health, and health systems. One such is the Institute of
Clinical Evaluation Studies (ICES) in Ontario, which is cele-
brating its 20th anniversary this year (http://www.ices.on.ca/
file/TWENTY_ICES_20th_Anniversary_Magazine.pdf).0895-4356/$ - see front matter  2013 Published by Elsevier Inc.
http://dx.doi.org/10.1016/j.jclinepi.2013.04.004This institute has administrative data on all the interactions
within the health system of all 13 million individuals in On-
tario; this is supplemented by registries such as the Canadian
Stroke Registry, Implantable Cardiac Device Registry, and
the Ontario Biologics Registry. Notable examples relevant
to clinical epidemiology and evidence-based health care im-
pacts have been the effects of publication of introducing wait
times algorithms for cardiac surgery patient safety such as
the higher mortality seen in hospitals; atlases on chronic dis-
ease showing the local prevalence rates that are needed for
pretest probabilities and for applying GRADE (http://www.
gradeworkinggroup.org/) to locally appropriate recommenda-
tions; atlases of variations in rates of events and practices to
provide peer pressure to improve practices (e.g., appendec-
tomy rates, caesarian rates, c.difficile hospital infections, car-
diac events in hospitals; dangers of cell phones while driving;
diabetes rates in vulnerable groups and their access to care
and nutritious food; the finding that spironolactone was asso-
ciated with toxic levels of potassium; and atypical bone frac-
tures with bisphosphonates).
In a related vein, in his provocatively entitled Commen-
tary ‘‘Quality-of-life data should be regarded as a vital
sign,’ Feeny argues that the health care system systemati-
cally collects data on inputs, such as risk factors, processes
of care, and the amount and type of services provided, but
the health system only sporadically collects data on the
health status and health-related quality of life (HRQL) of
those served. He argues that health-related quality-of-life
measures should be an integral component of chronic care
management and be routinely used to monitor the perfor-
mance of the health care system. Patients and clinicians
will need to be trained to exploit this powerful source of in-
formation, and administrators will need to support those
activities.
Quality of life. Tan et al. demonstrated measurement
equivalence of the English and Chinese versions of the
Short Form 36 version 2 (SF-36v2) and Short Form 6D
(SF-6D). Thus, because the two languages measure the
same construct, the results can be pooled together and con-
clusions can be made to both the language-speaking group
as a whole.
Instrument overload is always a concern, but should we
accept that a short form of even a widely used complete
original questionnaire inherits the same psychometric
700 Editorial / Journal of Clinical Epidemiology 66 (2013) 699e701properties and is equally valid and responsive? It may well
be that the improved feasibility may come at the cost of
worse validity (e.g., content) and responsiveness. Goetz
et al. found major worrying psychometric gaps in some
widely used questionnaires when they reviewed current
practice and update guidelines for the methodology of
shortening composite measurement scales. The authors pro-
pose some criteria for item reduction based on a rigorous
methodology is necessary if the short-form instrument aims
to maintain the validity and other measurement properties
of the parent instrument, which in turn supports application
in research and clinical practice. Consensus and a dissemi-
nation plan are needed if this parlous state is to change.
The next installment of the Grading of Recommenda-
tions Assessment, Development, and Evaluation (GRADE)
series is published this month with 2 papers by Andrews
et al. on classifying the direction and strength of recom-
mendations plus a report on the importance of training to
minimize interrater reliability. The first article posits that
the strength of a recommendation, separated into strong
and weak, is defined as the extent to which one can be con-
fident that the desirable effects of an intervention outweigh
its undesirable effects. The second article provides guid-
ance on how to move from the Grade Quality of Evidence
to the Grade Recommendations. This latter is to make ex-
plicit the basis of the Recommendation that is essentially
the balance of desirable and undesirable outcomes of inter-
est among alternative management strategies; this depends
on four domains, namely estimates of effect for desirable
and undesirable outcomes of interest, confidence in the es-
timates of effect, estimates of values and preferences, and
resource use. This article will be of notable interest to those
readers who have been awaiting more detailed guidance on
the values and preferences of patients and individuals af-
fected by or paying for the care of the condition of interest.
We agree that panels should strive to provide recommenda-
tions when asked; tough decisions should not by avoided by
taking the often all-to-easy way of declining to make rec-
ommendations and asking for more research and support,
which is the case made in these articles. In the third article,
by Mustafa et al., the inter-rater reliability of assessing the
quality of evidence using the GRADE approach was evalu-
ated. Their findings suggest that individuals trained using
the GRADE approach improve reliability in comparison
to intuitive judgments about the quality of evidence and
that 2 individual raters can reliably assess the quality of ev-
idence using the GRADE system.
Statistics. When the number of events is small during
Cox regression analysis because the events are rare or be-
cause it is a cohort study with long latency events, it is
unclear what alternative analytical strategies can be used
and when this type of alternative approach is needed. A
study by Lin et al. explores such alternative analytical strat-
egies. They found that when the primary predictor is cate-
gorical and when the events per variable is less than 6, the
Firth method can be used to obtain more accurateparameter estimates. Appropriate choices of priors using
Bayesian analysis should also be able to increase the accu-
racy of parameter estimates. The drawback of this ap-
proach, however, is that it requires more expertise. In
another article, Workman and colleagues provide a sample
size formula for cluster randomized stepped wedge designs.
The stepped wedge design is increasingly being used in
cluster randomized trials. However, there is little informa-
tion available about the design and analysis strategies for
these kinds of trials. Sample sizes are smaller than with
other designs, but a simple sample size formula has been
lacking. The formula they present in this paper corrects
for clustering as well as for the design.
Clinician compliance is as important as patient adher-
ence in achieving improved health outcomes. Little is
known about the relationship between clinical experience
and clinician compliance with the study protocol in ran-
domized clinical trials. Walter et al., in the context of a re-
cent randomized trial of surgical techniques for tibia
fracture fixation, raise the hypothesis that varying amounts
of clinical experience has been previously underemphasised
as an important cause of noncompliance by clinicians with
the randomly assigned treatment that can be highly detri-
mental to a study’s power may. They found that, in random-
ized clinical trials, noncompliance by clinicians with the
randomly assigned treatment was detrimental to the power
of the study. They conclude that further research is needed
in this area to identify, quantify, and understand the factors
associated with noncompliance, including clinical
experience.
Quality of life. Should we systematically throw out
widely used existing scales for measuring Patient Reported
Outcomes (PROs) if they fail the requirements of the ap-
proval agencies, such as the FDA guidance documents
[2]? Alliet et al. sought to determine the content, structural,
and construct validity of the Dutch version of the Neck Dis-
ability Index (NDI). They found that in addition to a subop-
timal translation, there was a lack of consensus on the
construct the NDI intends to measure. The authors advocate
the development of a new disease-specific instrument, start-
ing from a clear definition of the construct to be measured
and using more advanced psychometric techniques. In the
same spirit of patient-centeredness, Dannell and colleagues
sought to examine the difference between children and their
parents in reporting symptoms and treatment of allergic dis-
eases within a longitudinal birth cohort. Although reports of
allergic symptoms and treatment by 12-year-old children
and their parents were in moderate to good agreement, chil-
dren reported more symptoms than their parents. The au-
thors conclude that symptoms of allergic disease should
be reported by children themselves, from the age of 11
years, whereas questions of prescribed pharmacologic treat-
ment could be answered either by the children or their
parents.
Scoring systems for quality-of-life instruments need
to trade off their discriminative ability with simplicity.
701Editorial / Journal of Clinical Epidemiology 66 (2013) 699e701A paper by Forero et al. proposes a multidimensional item
response theory (MIRT) scoring system for the Short Form
12 (SF-12). The MIRT models showed a clear construct
structure for the physical and mental component score di-
mensions. Results support the use of SF-12 MIRT-based
scores as a valid and reliable option to assess health status,
but the score still needs computation rather simple
addition.
Finally, the third paper in our series on effective writing
and publishing of scientific papers provides some tips for
structuring and writing a concise introduction. Cals and
Kotz introduce the concept of the ‘funnel,’ starting with
the broad context and ending with a well-focused article.
Please read the article for more details.Peter Tugwell
J. Andre Knottnerus
Leanne Idzerda
Editors
E-mail address: lidzerda@uottawa.ca (L. Idzerda)
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